In the reference list of this article, reference 7 was incorrect and is replaced as follows:
7. Buse JB, Garg SK, Rosenstock J, et al. Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: the North American inTandem1 study. Diabetes Care 2018;41:1970–1980
In addition, in Table 1 the incidence rates in the placebo arm (IRPlb) and change in absolute risk (ΔIR) presented for the LEADER trial have been corrected, and Figure 2 has been revised using the corrected data.
The authors apologize for the errors. The online version of the article (https://doi.org/10.2337/dc20-0913) has been corrected to include the new reference and the revised figure and table.